Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - azelastinhydrochlorid, fluticasonpropionat - næsespray, suspension - 137+50 mikrog/dosis

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 100 mg

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 200 mg

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 25 mg

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 50 mg

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

glaxosmithkline pharma a/s - lamotrigin - tyggetabletter/dispergible tabletter - 5 mg

Европска Унија - Дански - EMA (European Medicines Agency)

amicus therapeutics europe limited - cipaglucosidase alfa - glycogen opbevaring sygdom type ii - andre alimentary tract and metabolism produkter, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

viatris aps - azelastinhydrochlorid, fluticasonpropionat - næsespray, suspension - 137+50 mikrog/dosis

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - azelastinhydrochlorid, fluticasonpropionat - næsespray, suspension - 137+50 mikrog/dosis

Данска - Дански - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - azelastinhydrochlorid, fluticasonpropionat - næsespray, suspension - 137+50 mikrog/dosis